|
BR112018008697A2
|
|
method and kit for vaccination against an autoantigen, use of a kit, and vaccine for use in vaccination.
|
|
US2018186896A1
|
|
Vaccines for the treatment and prevention of ige mediated diseases
|
|
US2018110846A1
|
|
IL-23-p19 vaccines
|
|
EP3192806A1
|
|
Alpha chain of the high-affinity ige receptor (fceria)
|
|
WO2016005545A1
|
|
Substances and methods for the use in prevention and/or treatment in huntington's disease
|
|
CN106687475A
|
|
Substances and methods for the use in prevention and/or treatment in huntington's disease
|
|
TW201623329A
|
|
Vaccines and monoclonal antibodies targeting truncated variants of osteopontin and uses thereof
|
|
WO2015185602A1
|
|
Treatment and prevention of parkinson's disease (pd)
|
|
KR20160145820A
|
|
Treatment and prevention of alzheimer's disease (ad)
|
|
WO2015165961A1
|
|
Treatment and prevention of alzheimer's disease (ad)
|
|
WO2015165971A1
|
|
Treatment and prevention of alzheimer's disease (ad)
|
|
WO2015165980A2
|
|
Treatment and prevention of alzheimer's disease (ad)
|
|
AU2015254665A1
|
|
Treatment and prevention of alzheimer's disease (AD)
|
|
KR20160145822A
|
|
Treatment and prevention of alzheimer's disease (ad)
|
|
AU2015222283A1
|
|
PCSK9 vaccines
|
|
TW201350509A
|
|
Vaccine
|
|
TW201348264A
|
|
Composition
|
|
EP2787349A1
|
|
Method for detecting proteinopathy-specific antibodies in a biological sample
|
|
EP2787347A1
|
|
Method for detecting Aß-specific antibodies in a biological sample
|
|
EP2787348A1
|
|
Method for detecting aSyn-specific antibodies in a biological sample
|
